On July 10, the state administration of pharmaceutical supervision and administration of the Peoples Republic of China issued the technical guidelines for the acceptance of data from clinical trials abroad, which recognized the simultaneous

Yesterday (26 July), MSD announced that its pd-1 single anti-keytruda (pd-1 single anti-keytruda) injection was officially approved in China. This is the second monoclonal anti-pd-1 / pd-l1 drug to enter China after bristol-myers squibbs Op

Now and in the future, innovation-driven has become the will of the nation. The pharmaceutical industry will return to the essence of the industry. A comprehensive analysis of outstanding enterprises in the past decade may be more instructi

Level 3 hospitals implement the second quotation within the hospital, and make clear the reduction of consumables. If the reduction is not achieved, the original consumables enterprises in the hospital may be eliminated. On August 1st, guil

In April and June this year, premier li keqiang presided over two executive meetings of the state council, which decided to implement zero tariffs on imported anticancer drugs and encourage the import of innovative drugs. Meeting decided to

During the seminar on the construction of a centralized production base for small-variety drugs (drugs in short supply) held in Shanghai in July, the supply guarantee consortium for national small-variety drugs (drugs in short supply) was e

On July 30, premier li keqiang presided over the executive meeting of the state council to hear the progress report of the investigation into the illegal production of rabies vaccine by jilin changsheng company. We will optimize the use str

According to a person familiar with the matter, recently, the pharmaceutical administration department of the national health and health commission drafted the opinions on further improving the national basic drug system, which is currently